NEW YORK, Dec. 12 – Celera Genomics and Syrrx said Wednesday they had formed a drug discovery research collaboration.

Structural genomics company Syrrx said it would use its technology for determining a protein’s structure to uncover the 3-D make-up of proteins Celera identifies as potential drug targets.

Celera said it would use the information generated through the collaboration to discover small molecule drugs. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.